• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸膜腔感染的病理生理学

Pathophysiology of pleural space infections.

作者信息

Antony V B, Mohammed K A

机构信息

Department of Medicine, Indiana University School of Medicine, Indianapolis 46202, USA.

出版信息

Semin Respir Infect. 1999 Mar;14(1):9-17.

PMID:10197393
Abstract

The pleura responds to the presence of infecting organisms with a vigorous inflammatory response associated with an exudation of white blood cells and proteins. Changes in pleural permeability lead to formation of an exudative pleural effusion. The pleural mesothelial cell is the primary cell lining the pleural space and, when activated by the presence of organisms, initiates the inflammatory response by releasing a battery of chemokines and cytokines. Mesothelial cells are actively phagocytic and also release oxidants and proteases. The acute inflammatory process may resolve with appropriate antibiotic therapy and drainage leaving minimal fibrosis. However, under certain circumstances vigorous pleural fibrosis with scarring and loss of delineation of pleural surfaces can occur. Recognition of the stage of development of the empyema is an important clinical judgement that can affect outcome. The pathogenesis of infections of the pleural space and the role played by the various cell types is delineated in this article.

摘要

胸膜对感染性生物体的存在会产生强烈的炎症反应,伴有白细胞和蛋白质渗出。胸膜通透性的改变导致渗出性胸腔积液的形成。胸膜间皮细胞是胸膜腔的主要内衬细胞,当被生物体激活时,会通过释放一系列趋化因子和细胞因子引发炎症反应。间皮细胞具有活跃的吞噬作用,还会释放氧化剂和蛋白酶。急性炎症过程可通过适当的抗生素治疗和引流得以缓解,仅留下极少的纤维化。然而,在某些情况下,可能会发生严重的胸膜纤维化,伴有瘢痕形成和胸膜表面界限不清。识别脓胸的发展阶段是一项重要的临床判断,可能会影响治疗结果。本文阐述了胸膜腔感染的发病机制以及各种细胞类型所起的作用。

相似文献

1
Pathophysiology of pleural space infections.胸膜腔感染的病理生理学
Semin Respir Infect. 1999 Mar;14(1):9-17.
2
[Physiopathology of pleural diseases].[胸膜疾病的病理生理学]
Rev Prat. 1997 Jun 15;47(12):1294-7.
3
Diagnosis and management of parapneumonic effusions and empyema.肺炎旁胸腔积液和脓胸的诊断与管理
Clin Infect Dis. 2007 Dec 1;45(11):1480-6. doi: 10.1086/522996. Epub 2007 Oct 24.
4
Pathogenesis of pleural fibrosis.胸膜纤维化的发病机制。
Respirology. 2004 Nov;9(4):428-40. doi: 10.1111/j.1440-1843.2004.00633.x.
5
[Current value of intrapleural fibrinolysis in the treatment of exudative fibrinous pleural effusions in pleural empyema and hemothorax].[胸膜内纤维蛋白溶解疗法在治疗脓胸和血胸所致渗出性纤维蛋白性胸腔积液中的当前价值]
Pneumologie. 1999 Aug;53(8):373-84.
6
Pathology of pleural infections.胸膜感染的病理学
Semin Respir Infect. 1988 Dec;3(4):291-7.
7
[Parapneumonic pleural effusion, pleural empyema: medical and surgical aspects].[肺炎旁胸腔积液、胸膜腔积脓:医学与外科方面]
Schweiz Med Wochenschr. 1999 Apr 10;129(14):556-62.
8
Pleural fibrosis.胸膜纤维化
Clin Chest Med. 2006 Jun;27(2):181-91. doi: 10.1016/j.ccm.2005.12.003.
9
The definitions and epidemiology of pleural space infection.胸膜腔感染的定义与流行病学
Semin Respir Infect. 1999 Mar;14(1):3-8.
10
Role of mesothelial and submesothelial stromal cells in matrix remodeling following pleural injury.间皮细胞和间皮下基质细胞在胸膜损伤后基质重塑中的作用。
Am J Pathol. 1993 Feb;142(2):547-55.

引用本文的文献

1
Clinical overview of the physiology and pathophysiology of pleural fluid movement: a narrative review.胸腔积液流动的生理学与病理生理学临床概述:一篇叙述性综述
ERJ Open Res. 2024 Sep 30;10(5). doi: 10.1183/23120541.00050-2024. eCollection 2024 Sep.
2
Update on Novel Targeted Therapy for Pleural Organization and Fibrosis.胸膜组织和纤维化的新型靶向治疗进展。
Int J Mol Sci. 2022 Jan 29;23(3):1587. doi: 10.3390/ijms23031587.
3
Management of pleural empyema in a 12-year-old obese patient with COVID-19: a pediatric case report.
12 岁肥胖 COVID-19 患儿脓胸的处理:儿科病例报告。
BMC Pediatr. 2021 Nov 30;21(1):531. doi: 10.1186/s12887-021-03007-1.
4
Transmembrane Tumor Necrosis Factor Controls Myeloid-Derived Suppressor Cell Activity TNF Receptor 2 and Protects from Excessive Inflammation during BCG-Induced Pleurisy.跨膜肿瘤坏死因子控制髓源性抑制细胞活性、肿瘤坏死因子受体2,并在卡介苗诱导的胸膜炎期间防止过度炎症。
Front Immunol. 2017 Aug 25;8:999. doi: 10.3389/fimmu.2017.00999. eCollection 2017.
5
Profile of Metalloproteinases and Their Association with Inflammatory Markers in Pleural Effusions.胸腔积液中金属蛋白酶及其与炎症标志物的相关性分析。
Lung. 2016 Dec;194(6):1021-1027. doi: 10.1007/s00408-016-9945-5. Epub 2016 Sep 27.
6
Moxifloxacin pharmacokinetics and pleural fluid penetration in patients with pleural effusion.莫西沙星在胸腔积液患者中的药代动力学及胸膜腔穿透情况。
Antimicrob Agents Chemother. 2014;58(3):1315-9. doi: 10.1128/AAC.02291-13. Epub 2013 Dec 9.
7
Angiogenic factors and angiogenesis inhibitors in exudative pleural effusions.渗出性胸腔积液中的血管生成因子与血管生成抑制剂
Lung. 2005 May-Jun;183(3):185-95. doi: 10.1007/s00408-004-2533-0.
8
Morphological analysis of leucocyte transmigration in the pleural cavity.胸腔内白细胞迁移的形态学分析
J Anat. 2003 Oct;203(4):391-404. doi: 10.1046/j.1469-7580.2003.00231.x.